Your browser doesn't support javascript.
loading
Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage.
Deng, Haibin; Gao, Yanyun; Trappetti, Verdiana; Hertig, Damian; Karatkevich, Darya; Losmanova, Tereza; Urzi, Christian; Ge, Huixiang; Geest, Gerrit Adriaan; Bruggmann, Remy; Djonov, Valentin; Nuoffer, Jean-Marc; Vermathen, Peter; Zamboni, Nicola; Riether, Carsten; Ochsenbein, Adrian; Peng, Ren-Wang; Kocher, Gregor Jan; Schmid, Ralph Alexander; Dorn, Patrick; Marti, Thomas Michael.
Afiliação
  • Deng H; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Gao Y; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Trappetti V; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Hertig D; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Karatkevich D; Institute of Anatomy, University of Bern, Bern, Switzerland.
  • Losmanova T; Department of Neuroradiology, University of Bern, Bern, Switzerland.
  • Urzi C; Institute of Clinical Chemistry, University Hospital Bern, Bern, Switzerland.
  • Ge H; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Geest GA; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Bruggmann R; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
  • Djonov V; Institute of Pathology, University of Bern, Bern, Switzerland.
  • Nuoffer JM; Department of Neuroradiology, University of Bern, Bern, Switzerland.
  • Vermathen P; Institute of Clinical Chemistry, University Hospital Bern, Bern, Switzerland.
  • Zamboni N; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
  • Riether C; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Ochsenbein A; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Peng RW; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
  • Kocher GJ; Interfaculty Bioinformatics Unit, Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland.
  • Schmid RA; Interfaculty Bioinformatics Unit, Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland.
  • Dorn P; Institute of Anatomy, University of Bern, Bern, Switzerland.
  • Marti TM; Department of Neuroradiology, University of Bern, Bern, Switzerland.
Cell Mol Life Sci ; 79(8): 445, 2022 Jul 25.
Article em En | MEDLINE | ID: mdl-35877003
ABSTRACT
Once considered a waste product of anaerobic cellular metabolism, lactate has been identified as a critical regulator of tumorigenesis, maintenance, and progression. The putative primary function of lactate dehydrogenase B (LDHB) is to catalyze the conversion of lactate to pyruvate; however, its role in regulating metabolism during tumorigenesis is largely unknown. To determine whether LDHB plays a pivotal role in tumorigenesis, we performed 2D and 3D in vitro experiments, utilized a conventional xenograft tumor model, and developed a novel genetically engineered mouse model (GEMM) of non-small cell lung cancer (NSCLC), in which we combined an LDHB deletion allele with an inducible model of lung adenocarcinoma driven by the concomitant loss of p53 (also known as Trp53) and expression of oncogenic KRAS (G12D) (KP). Here, we show that epithelial-like, tumor-initiating NSCLC cells feature oxidative phosphorylation (OXPHOS) phenotype that is regulated by LDHB-mediated lactate metabolism. We show that silencing of LDHB induces persistent mitochondrial DNA damage, decreases mitochondrial respiratory complex activity and OXPHOS, resulting in reduced levels of mitochondria-dependent metabolites, e.g., TCA intermediates, amino acids, and nucleotides. Inhibition of LDHB dramatically reduced the survival of tumor-initiating cells and sphere formation in vitro, which can be partially restored by nucleotide supplementation. In addition, LDHB silencing reduced tumor initiation and growth of xenograft tumors. Furthermore, we report for the first time that homozygous deletion of LDHB significantly reduced lung tumorigenesis upon the concomitant loss of Tp53 and expression of oncogenic KRAS without considerably affecting the animal's health status, thereby identifying LDHB as a potential target for NSCLC therapy. In conclusion, our study shows for the first time that LDHB is essential for the maintenance of mitochondrial metabolism, especially nucleotide metabolism, demonstrating that LDHB is crucial for the survival and proliferation of NSCLC tumor-initiating cells and tumorigenesis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article